Emflaza
Deflazacort
Emflaza is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients at the age of 5 and older.
more
| Package | Per pill | Price | Savings | Order |
|---|---|---|---|---|
|
120 tablet
Free AirMail shipping
Hot
|
C$ 6.26
|
C$ 750.74C$ 6.26
|
C$ 136.24
|
|
|
90 tablet
Free AirMail shipping
Hot
|
C$ 6.60
|
C$ 593.75C$ 6.60
|
C$ 71.48
|
|
|
60 tablet
Free AirMail shipping
Hot
|
C$ 6.82
|
C$ 409.46C$ 6.82
|
C$ 34.03
|
|
|
36 tablet
Free AirMail shipping
Hot
|
C$ 7.20
|
C$ 259.30C$ 7.20
|
C$ 6.79
|
|
|
24 tablet
|
C$ 7.39
|
C$ 177.39C$ 7.39
|
|
| Package | Per pill | Price | Savings | Order |
|---|---|---|---|---|
|
90 tablet
Free AirMail shipping
Hot
|
C$ 7.58
|
C$ 682.48C$ 7.58
|
C$ 136.32
|
|
|
60 tablet
Free AirMail shipping
Hot
|
C$ 8.19
|
C$ 491.37C$ 8.19
|
C$ 54.50
|
|
|
36 tablet
Free AirMail shipping
Hot
|
C$ 8.72
|
C$ 313.90C$ 8.72
|
C$ 13.62
|
|
|
24 tablet
Free AirMail shipping
Hot
|
C$ 9.10
|
C$ 218.35C$ 9.10
|
|
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.
